216 related articles for article (PubMed ID: 31673075)
1. Prediction and Analysis of Skin Cancer Progression using Genomics Profiles of Patients.
Bhalla S; Kaur H; Dhall A; Raghava GPS
Sci Rep; 2019 Oct; 9(1):15790. PubMed ID: 31673075
[TBL] [Abstract][Full Text] [Related]
2. Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
Li Y; Li M; Shats I; Krahn JM; Flake GP; Umbach DM; Li X; Li L
PLoS One; 2019; 14(6):e0218067. PubMed ID: 31199813
[TBL] [Abstract][Full Text] [Related]
3. Integrative Analysis of Long Noncoding RNA (lncRNA), microRNA (miRNA) and mRNA Expression and Construction of a Competing Endogenous RNA (ceRNA) Network in Metastatic Melanoma.
Wang LX; Wan C; Dong ZB; Wang BH; Liu HY; Li Y
Med Sci Monit; 2019 Apr; 25():2896-2907. PubMed ID: 31004080
[TBL] [Abstract][Full Text] [Related]
4. Toward predicting metastatic progression of melanoma based on gene expression data.
Li Y; Krahn JM; Flake GP; Umbach DM; Li L
Pigment Cell Melanoma Res; 2015 Jul; 28(4):453-63. PubMed ID: 25847062
[TBL] [Abstract][Full Text] [Related]
5. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles.
Kaur H; Bhalla S; Raghava GPS
PLoS One; 2019; 14(9):e0221476. PubMed ID: 31490960
[TBL] [Abstract][Full Text] [Related]
6. Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma.
Bhalla S; Kaur H; Kaur R; Sharma S; Raghava GPS
PLoS One; 2020; 15(4):e0231629. PubMed ID: 32324757
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in malignant melanoma.
Völler D; Ott C; Bosserhoff A
Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
[TBL] [Abstract][Full Text] [Related]
8. The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma.
Zhao Y; Liu X; Zhong L; He M; Chen S; Wang T; Ma S
Int J Mol Med; 2015 Oct; 36(4):1097-103. PubMed ID: 26252081
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
[TBL] [Abstract][Full Text] [Related]
10. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Analysis Identifies MicroRNAs and Target Genes Associated with Prognosis in Patients with Melanoma.
Li Q; Zhang LY; Wu S; Huang C; Liu J; Wang P; Cao Y
Med Sci Monit; 2019 Oct; 25():7784-7794. PubMed ID: 31621692
[TBL] [Abstract][Full Text] [Related]
12. sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses.
Zhang CL; Xu YJ; Yang HX; Xu YQ; Shang DS; Wu T; Zhang YP; Li X
Sci Rep; 2017 Nov; 7(1):15322. PubMed ID: 29127397
[TBL] [Abstract][Full Text] [Related]
13. Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View.
Korfiati A; Grafanaki K; Kyriakopoulos GC; Skeparnias I; Georgiou S; Sakellaropoulos G; Stathopoulos C
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163222
[TBL] [Abstract][Full Text] [Related]
14. Global microRNA profiling of metastatic conjunctival melanoma.
Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
[TBL] [Abstract][Full Text] [Related]
15. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Zhu Y; Wen X; Zhao P
Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
[TBL] [Abstract][Full Text] [Related]
17. Deep sequencing analysis of microRNA expression in human melanocyte and melanoma cell lines.
Ding N; Wang S; Yang Q; Li Y; Cheng H; Wang J; Wang D; Deng Y; Yang Y; Hu S; Zhao H; Fang X
Gene; 2015 Nov; 572(1):135-145. PubMed ID: 26164755
[TBL] [Abstract][Full Text] [Related]
18. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma.
Xin X; Zhang Y; Ling F; Wang L; Sheng X; Qin L; Zhao X
Exp Eye Res; 2019 Mar; 180():242-249. PubMed ID: 30615885
[TBL] [Abstract][Full Text] [Related]
19. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D
Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
